Showing results (391-400 of 530) with videos related to
Sort By:
Pageof 53
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 23, 2022
A validation of models for prediction of pathogenic variants in mismatch repair genesCathy Shyr, Amanda L Blackford, Theodore Huang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2020
A Multi-Institutional Cohort of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer SurvivorsLeah H Biller, Chinedu Ukaegbu, Tara G Dhingra, et al.Cancer|January 17, 2018
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinomaEileen M O'Reilly, Jonathan W Lee, Maeve A Lowery, et al.NPJ Precision Oncology|November 19, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrumKelsey E Breen, Nikita Mehta, Vignesh Ravichandran, et al.Cancer Discovery|June 17, 2018
Precision Prevention and Early Detection of Cancer: Fundamental PrinciplesTimothy R Rebbeck, Karen Burns-White, Andrew T Chan, et al.Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.Journal of the American Medical Informatics Association : JAMIA|March 7, 2019
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Arlene E Chung, Kimberly Shoenbill, Sandra A Mitchell, et al.Clinical Trials (London, England)|October 23, 2024
Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sampleCarolyn Mead-Harvey, Ethan Basch, Lauren J Rogak, et al.Pageof 53